ClinConnect ClinConnect Logo
Search / Trial NCT06525441

Dietary Protein Sources and Glycemic Variability

Launched by GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL · Jul 24, 2024

Trial Information

Current as of August 20, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how different types of diets—plant-based versus animal-based—affect blood sugar levels in overweight or obese adults. The main question researchers want to answer is whether a plant-based diet can help reduce changes in blood sugar levels more effectively than an animal-based diet. Over the course of three weeks, participants will strictly follow one of these diets and wear a device that continuously monitors their blood sugar. They will also attend weekly check-ins and keep track of what they eat each day.

To take part in this study, individuals should be between 20 and 65 years old, have a body mass index (BMI) greater than 25, and be able to use a smartphone app to record their meals. Participants must have stable body weight and be capable of living independently. However, those with diagnosed diabetes, certain health conditions, or allergies that could be triggered by the diets will not be eligible. This study is not yet recruiting participants, but it aims to help us understand the best dietary choices for managing blood sugar in those who are overweight or obese.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Men or women aged 20-65 years.
  • 2. Body Mass Index (BMI) greater than 25kg/m2.
  • 3. Capable of using a smartphone application daily for taking photos and recording dietary intake.
  • 4. Maintained stable body weight over the past three months with a regular routine.
  • 5. Possess self-care ability for independent living.
  • 6. Not currently participating in any other clinical research projects.
  • 7. Signed the informed consent form and willing to adhere to and complete the entire research process.
  • Exclusion Criteria:
  • 1. With diagnosed diabetes.
  • 2. With severe cardiovascular or cerebrovascular diseases (e.g., angina, myocardial infarction, or stroke) or cancer.
  • 3. Taking medications affecting weight or energy intake/energy expenditure in the last 3 months, including weight loss medications, antipsychotic drugs or other medications as determined by the study physician.
  • 4. Participating in weight loss treatments.
  • 5. History of severe gastrointestinal diseases or gastrointestinal surgery within the past 12 months.
  • 6. Those with allergic reactions to common foods (for example, eggs, nuts, grains) or those who are lactose intolerant.
  • 7. Women who are pregnant or plan to become pregnant.
  • 8. Diagnosis of HIV, hepatitis B or C, or active tuberculosis.
  • 9. Special groups who are specifically unsuitable for a diet consisting of whole plant proteins.
  • 10. Patients who are unwilling or unable to give informed consent.

About Guangdong Provincial People's Hospital

Guangdong Provincial People's Hospital is a leading tertiary healthcare institution located in Guangdong Province, China, renowned for its comprehensive medical services and advanced research capabilities. As a prominent clinical trial sponsor, the hospital is dedicated to advancing medical science through innovative research and the rigorous evaluation of new therapies and interventions. With a multidisciplinary team of experienced clinicians and researchers, the institution prioritizes patient safety and ethical standards while fostering collaborations with academic and industry partners to enhance healthcare outcomes and contribute to the global medical community.

Locations

Patients applied

0 patients applied

Trial Officials

Jie Li

Principal Investigator

Guangdong Provincial People's Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported